Vincent J. Santora

Structure−Activity Relationships of a Series of Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives and Related Compounds as Neuropeptide Y5 Receptor Antagonists

Mark H. Norman, Ning Chen, Zhidong Chen et al. · Journal of Medicinal Chemistry · 2000 · 84 citations · Full text

Food Intake, Pharmacotherapy, Chemical Biology +18

Discovery and Evaluation of Dual CDK1 and CDK2 Inhibitors

Marc Payton, Grace Chung, P. Yakowec et al. · Cancer Research · 2006 · 80 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +13

Complexation of benzamidinium by a new family of artificial receptors

Thomas W. Bell, Vincent J. Santora · Journal of the American Chemical Society · 1992 · 43 citations

Combinatorial Chemistry, Bioorganic Chemistry, Altmetric Attention Score +17

Cyclobutenone-Based Syntheses of Polyquinanes and Bicyclo[6.3.0]undecanes by Tandem Anionic Oxy-Cope Reactions. Total Synthesis of (±)-Precapnelladiene

James M. MacDougall, Vincent J. Santora, Sharad K. Verma et al. · The Journal of Organic Chemistry · 1998 · 38 citations

Chemical Engineering, Engineering, Heterocyclic +11

Structure–activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors

Robert M. Rzasa, Matthew R. Kaller, Gang Liu et al. · Bioorganic & Medicinal Chemistry · 2007 · 37 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Potential Cdk5 Inhibitors +8